Integrated Report

Overview

The report describes Kirin Group's 2023 performance across Food & Beverages, Pharmaceuticals, and Health Science, including consolidated revenue of 2,134.4 billion yen and record normalized operating profit. It highlights a 31% reduction in Scope 1+2 GHG emissions versus 2019, alongside a 2050 net-zero target and a 2030 50% reduction target. Human-capital disclosures include a consolidated workforce of 30,183 and 70% employee engagement. The report also details the Group's revised human rights policy, TCFD/TNFD disclosures, and CSV commitments.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

SBTi status

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services